Cargando…
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series
OBJECTIVES: Three new chemical series (bicyclic nitroimidazoles, aminopyrazoles and oxaboroles) were selected by Drugs for Neglected Diseases initiative as potential new drug leads for leishmaniasis. Pharmacodynamics studies included both in vitro and in vivo efficacy, cross-resistance profiling aga...
Autores principales: | Van den Kerkhof, M., Mabille, D., Chatelain, E., Mowbray, C.E., Braillard, S., Hendrickx, S., Maes, L., Caljon, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114106/ https://www.ncbi.nlm.nih.gov/pubmed/29425734 http://dx.doi.org/10.1016/j.ijpddr.2018.01.006 |
Ejemplares similares
-
Antileishmanial Aminopyrazoles: Studies into Mechanisms and Stability of Experimental Drug Resistance
por: Van den Kerkhof, M., et al.
Publicado: (2020) -
Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series
por: Van den Kerkhof, Magali, et al.
Publicado: (2021) -
Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
por: Koovits, Paul J., et al.
Publicado: (2020) -
Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum
por: Hendrickx, Sarah, et al.
Publicado: (2017) -
In vitro antileishmanial and antimalarial activity of selected plants of Nepal
por: Joshi, Bishnu, et al.
Publicado: (2016)